Envisagenics
Envisagenics is a biotechnology company that is focused on the development of RNA splicing therapeutics utilizing artificial intelligence.
Last updated on
About Envisagenics
Founded
2014Estimated Revenue
$1M-$10MEmployees
11-50Funding / Mkt. Cap
$27MCategory
Industry
Health ServicesLocation
City
New York CityState
New YorkCountry
United StatesTech Stack (48)
